人类增强剂的突变变异性敏感度映射In Vivo
Michael Kosicki1, Boyang Zhang2, Anusri Pampari2,3
1Environmental Genomics & System Biology Division, Lawrence Berkeley National Laboratory, One Cyclotron Road, Berkeley, CA 94720, USA.
bioRxiv : the preprint server for biology
|September 16, 2024
概括
人类发育增强剂具有许多关键的DNA序列. 大多数突变会破坏增强器的功能,突出显示它们在发育和疾病中的重要性. 这项研究绘制了这些基本特征.
科学领域:
- 遗传学 遗传学是一种遗传学.
- 发展生物学 发展生物学
- 基因组学就是基因组学.
背景情况:
- 远程作用增强剂对人类发展至关重要.
- 了解增强器序列功能对于解释致病突变至关重要.
研究的目的:
- 为了确定人类发育增强剂在体内对突变发生的功能敏感性.
- 在增强剂中识别关键核酸和序列特征.
主要方法:
- 在7种人类发育增强剂中,12个基对块的系统性突变发生.
- 产生超过1700个转基因小鼠以评估体内增强剂活性.
- 预测建模和机器学习的应用,以注释功能核酸.
主要成果:
- 69%的突变块破坏了正常的体内增强剂活性.
- 突变更频繁地导致功能丧失 (60%),而不是功能增加 (9%).
- 机器学习模型准确地预测了功能动机,识别了59%的功能障碍.
结论:
- 人类增强剂具有高密度的序列特征,对于体内功能至关重要.
- 这项研究为了解增强器功能和人类发展提供了基础资源.
更多相关视频
相关概念视频
01:16In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K